Extending Angiomax after PCI Unhelpful

ACC Conference Reporter

ESC 2015 | LONDON — The final piece of the MATRIX puzzle on use of bivalirudin (Angiomax) in percutaneous coronary interventions has come in: The extension of use of the drug following the procedures does not prevent bleeding or stent thromboses any better than not extending its use for at least an additional 4 hours, researchers reported here. Read More >>>

Keywords: ESC Congress

< Back to Listings